SCHEMBL3683672

SCHEMBL3683672

Cc1nn(-c2ccccn2)c(C)c1-c1ccccc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.50
HPGD P15428 3/20 0.50
HSD17B10 Q99714 3/20 0.50
ALOX15 P16050 1/20 0.50
SMN1; SMN2 Q16637 4/20 0.48
MAPT P10636 4/20 0.48
THRB P10828 1/20 0.48
TDP1 Q9NUW8 1/20 0.48
KDM4E B2RXH2 3/20 0.48
SLC11A2 P49281 1/20 0.48
NPC1 O15118 3/20 0.47
RAB9A P51151 3/20 0.47
CCNA2 P20248 8/20 0.46
CDK2 P24941 8/20 0.46
TP53 P04637 1/20 0.45
HTT P42858 1/20 0.45
L3MBTL1 Q9Y468 1/20 0.45
CCNO P22674 1/20 0.45
CCNE1 P24864 1/20 0.45
CCNA1 P78396 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19754131 0.90 HPGD (0.45) ALDH1A1HPGDHSD17B10ALOX15SMN1; SMN2
SCHEMBL4748541 0.84 SMN1; SMN2 (0.65) ALDH1A1HPGDHSD17B10SMN1; SMN2MAPT
SCHEMBL4746341 0.84 ALDH1A1 (0.48) ALDH1A1HPGDHSD17B10ALOX15SMN1; SMN2
SCHEMBL18949733 0.80 ALDH1A1 (0.55) ALDH1A1HPGDHSD17B10ALOX15SMN1; SMN2
SCHEMBL31500060 0.78 SMN1; SMN2 (0.69) ALDH1A1HPGDSMN1; SMN2MAPTTDP1
SCHEMBL7506607 0.77 SMN1; SMN2 (0.59) ALDH1A1HPGDHSD17B10ALOX15SMN1; SMN2
SCHEMBL6096779 0.76 NPC1 (0.40) SMN1; SMN2MAPTTHRBKDM4ENPC1
SCHEMBL27780413 0.75 ALDH1A1 (0.51) ALDH1A1HPGDHSD17B10ALOX15SMN1; SMN2
SCHEMBL3683961 0.75 ALDH1A1 (0.43) ALDH1A1HPGDHSD17B10ALOX15SMN1; SMN2
SCHEMBL16019533 0.74 ALDH1A1 (0.50) ALDH1A1HPGDHSD17B10ALOX15SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2010005851-A1 COMBINATION THERAPY FOR TREATING IRON DISORDERS XENON PHARMACEUTICALS INC. (CA) 2010-01-14 WO claimed
WO-2008121861-A2 PYRAZOLE AND PYRROLE COMPOUNDS USEFUL IN TREATING IRON DISORDERS XENON PHARMACEUTICALS INC. (CA) 2008-10-09 WO claimed
WO-2010005851-A1 COMBINATION THERAPY FOR TREATING IRON DISORDERS XENON PHARMACEUTICALS INC. (CA) 2010-01-14 WO disclosed
WO-2008121861-A2 PYRAZOLE AND PYRROLE COMPOUNDS USEFUL IN TREATING IRON DISORDERS XENON PHARMACEUTICALS INC. (CA) 2008-10-09 WO disclosed
WO-2008121861-A2 PYRAZOLE AND PYRROLE COMPOUNDS USEFUL IN TREATING IRON DISORDERS XENON PHARMACEUTICALS INC. (CA) 2008-10-09 WO disclosed